| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
The cellular and molecular basis of hyperthermia.
|
Crit Rev Oncol Hematol
|
2002
|
4.14
|
|
2
|
Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: a randomised phase 3 multicentre study.
|
Lancet Oncol
|
2010
|
2.66
|
|
3
|
Intracranial thermotherapy using magnetic nanoparticles combined with external beam radiotherapy: results of a feasibility study on patients with glioblastoma multiforme.
|
J Neurooncol
|
2006
|
2.22
|
|
4
|
Dynamic expression profile of p21WAF1/CIP1 and Ki-67 predicts survival in rectal carcinoma treated with preoperative radiochemotherapy.
|
J Clin Oncol
|
2003
|
2.04
|
|
5
|
Efficacy and safety of intratumoral thermotherapy using magnetic iron-oxide nanoparticles combined with external beam radiotherapy on patients with recurrent glioblastoma multiforme.
|
J Neurooncol
|
2010
|
2.02
|
|
6
|
Thermotherapy of prostate cancer using magnetic nanoparticles: feasibility, imaging, and three-dimensional temperature distribution.
|
Eur Urol
|
2006
|
2.00
|
|
7
|
Dose-escalated conformal radiotherapy of glioblastomas -- results of a retrospective comparison applying radiation doses of 60 and 70 Gy.
|
Onkologie
|
2005
|
1.72
|
|
8
|
Immunogenicity of premalignant lesions is the primary cause of general cytotoxic T lymphocyte unresponsiveness.
|
J Exp Med
|
2008
|
1.70
|
|
9
|
Hyperfractionated accelerated chemoradiation with concurrent fluorouracil-mitomycin is more effective than dose-escalated hyperfractionated accelerated radiation therapy alone in locally advanced head and neck cancer: final results of the radiotherapy cooperative clinical trials group of the German Cancer Society 95-06 Prospective Randomized Trial.
|
J Clin Oncol
|
2005
|
1.69
|
|
10
|
Magnetic nanoparticle hyperthermia for prostate cancer.
|
Int J Hyperthermia
|
2010
|
1.50
|
|
11
|
CT-guided interstitial brachytherapy of liver malignancies alone or in combination with thermal ablation: phase I-II results of a novel technique.
|
Int J Radiat Oncol Biol Phys
|
2004
|
1.38
|
|
12
|
Noninvasive magnetic resonance thermography of soft tissue sarcomas during regional hyperthermia: correlation with response and direct thermometry.
|
Cancer
|
2006
|
1.28
|
|
13
|
Description and characterization of the novel hyperthermia- and thermoablation-system MFH 300F for clinical magnetic fluid hyperthermia.
|
Med Phys
|
2004
|
1.26
|
|
14
|
A practical approach to thermography in a hyperthermia/magnetic resonance hybrid system: validation in a heterogeneous phantom.
|
Int J Radiat Oncol Biol Phys
|
2005
|
1.08
|
|
15
|
Liver malignancies: CT-guided interstitial brachytherapy in patients with unfavorable lesions for thermal ablation.
|
J Vasc Interv Radiol
|
2004
|
1.06
|
|
16
|
Local response and impact on survival after local ablation of liver metastases from colorectal carcinoma by computed tomography-guided high-dose-rate brachytherapy.
|
Int J Radiat Oncol Biol Phys
|
2010
|
1.03
|
|
17
|
Quantitative measurement of leakage volume and permeability in gliomas, meningiomas and brain metastases with dynamic contrast-enhanced MRI.
|
Magn Reson Imaging
|
2005
|
1.01
|
|
18
|
Response prediction by FDG-PET after neoadjuvant radiochemotherapy and combined regional hyperthermia of rectal cancer: correlation with endorectal ultrasound and histopathology.
|
Eur J Nucl Med Mol Imaging
|
2004
|
1.01
|
|
19
|
Contribution of 68Ga-DOTATOC PET/CT to target volume delineation of skull base meningiomas treated with stereotactic radiation therapy.
|
Int J Radiat Oncol Biol Phys
|
2012
|
0.99
|
|
20
|
Adaptation of antenna profiles for control of MR guided hyperthermia (HT) in a hybrid MR-HT system.
|
Med Phys
|
2007
|
0.97
|
|
21
|
Brain tumor perfusion: comparison of dynamic contrast enhanced magnetic resonance imaging using T1, T2, and T2* contrast, pulsed arterial spin labeling, and H2(15)O positron emission tomography.
|
Eur J Radiol
|
2008
|
0.97
|
|
22
|
Non-invasive magnetic resonance thermography during regional hyperthermia.
|
Int J Hyperthermia
|
2010
|
0.96
|
|
23
|
Photoelectric-enhanced radiation therapy with quasi-monochromatic computed tomography.
|
Med Phys
|
2009
|
0.96
|
|
24
|
Clinical use of the hyperthermia treatment planning system HyperPlan to predict effectiveness and toxicity.
|
Int J Radiat Oncol Biol Phys
|
2003
|
0.96
|
|
25
|
Computed tomography-guided high-dose-rate brachytherapy in hepatocellular carcinoma: safety, efficacy, and effect on survival.
|
Int J Radiat Oncol Biol Phys
|
2010
|
0.96
|
|
26
|
Noninvasive magnetic resonance thermography of recurrent rectal carcinoma in a 1.5 Tesla hybrid system.
|
Cancer Res
|
2005
|
0.95
|
|
27
|
Evaluation of MR-induced hot spots for different temporal SAR modes using a time-dependent finite difference method with explicit temperature gradient treatment.
|
IEEE Trans Biomed Eng
|
2007
|
0.94
|
|
28
|
Potentials of on-line repositioning based on implanted fiducial markers and electronic portal imaging in prostate cancer radiotherapy.
|
Radiat Oncol
|
2009
|
0.94
|
|
29
|
123I-IMT SPECT and 1H MR-spectroscopy at 3.0 T in the differential diagnosis of recurrent or residual gliomas: a comparative study.
|
J Neurooncol
|
2004
|
0.92
|
|
30
|
CT-guided interstitial brachytherapy of primary and secondary lung malignancies: results of a prospective phase II trial.
|
Strahlenther Onkol
|
2008
|
0.91
|
|
31
|
Radiobiological restrictions and tolerance doses of repeated single-fraction hdr-irradiation of intersecting small liver volumes for recurrent hepatic metastases.
|
Radiat Oncol
|
2010
|
0.90
|
|
32
|
Design and evaluation of a hybrid radiofrequency applicator for magnetic resonance imaging and RF induced hyperthermia: electromagnetic field simulations up to 14.0 Tesla and proof-of-concept at 7.0 Tesla.
|
PLoS One
|
2013
|
0.89
|
|
33
|
Computed-tomography-guided high-dose-rate brachytherapy (CT-HDRBT) ablation of metastases adjacent to the liver hilum.
|
Eur J Radiol
|
2013
|
0.89
|
|
34
|
Hepatocellular carcinoma: computed-tomography-guided high-dose-rate brachytherapy (CT-HDRBT) ablation of large (5-7 cm) and very large (>7 cm) tumours.
|
Eur Radiol
|
2011
|
0.89
|
|
35
|
Regional abdominal hyperthermia combined with systemic chemotherapy for the treatment of patients with ovarian cancer relapse: Results of a pilot study.
|
Int J Hyperthermia
|
2010
|
0.89
|
|
36
|
Regional hyperthermia in conjunction with definitive radiotherapy against recurrent or locally advanced prostate cancer T3 pN0 M0.
|
Strahlenther Onkol
|
2005
|
0.88
|
|
37
|
Computed tomography-guided brachytherapy for liver cancer.
|
Semin Radiat Oncol
|
2011
|
0.87
|
|
38
|
In vivo assessment of dose volume and dose gradient effects on the tolerance dose of small liver volumes after single-fraction high-dose-rate 192Ir irradiation.
|
Radiat Res
|
2009
|
0.87
|
|
39
|
[CT-Guided brachytherapy. A novel percutaneous technique for interstitial ablation of liver metastases].
|
Strahlenther Onkol
|
2004
|
0.87
|
|
40
|
Quantitative in vivo assessment of radiation injury of the liver using Gd-EOB-DTPA enhanced MRI: tolerance dose of small liver volumes.
|
Radiat Oncol
|
2011
|
0.86
|
|
41
|
In vivo assessment of the tolerance dose of small liver volumes after single-fraction HDR irradiation.
|
Int J Radiat Oncol Biol Phys
|
2005
|
0.86
|
|
42
|
CT-guided interstitial brachytherapy in the local treatment of extrahepatic, extrapulmonary secondary malignancies.
|
Eur Radiol
|
2006
|
0.85
|
|
43
|
Radiotherapy of liver metastases. Comparison of target volumes and dose-volume histograms employing CT- or MRI-based treatment planning.
|
Strahlenther Onkol
|
2008
|
0.85
|
|
44
|
In vivo assessment of the gastric mucosal tolerance dose after single fraction, small volume irradiation of liver malignancies by computed tomography-guided, high-dose-rate brachytherapy.
|
Int J Radiat Oncol Biol Phys
|
2006
|
0.85
|
|
45
|
Computed tomography-guided interstitial HDR brachytherapy (CT-HDRBT) of the liver in patients with irresectable intrahepatic cholangiocarcinoma.
|
Cardiovasc Intervent Radiol
|
2011
|
0.85
|
|
46
|
Genetic dissection of apoptosis and cell cycle control in response of colorectal cancer treated with preoperative radiochemotherapy.
|
BMC Cancer
|
2006
|
0.84
|
|
47
|
CT-guided interstitial single-fraction brachytherapy of lung tumors: phase I results of a novel technique.
|
Chest
|
2005
|
0.84
|
|
48
|
Imaging-therapy computed tomography with quasi-monochromatic X-rays.
|
Eur J Radiol
|
2008
|
0.83
|
|
49
|
Radiation exposure to patient and staff in hepatic chemoembolization: risk estimation of cancer and deterministic effects.
|
Cardiovasc Intervent Radiol
|
2006
|
0.83
|
|
50
|
Safety margin in irradiation of colorectal liver metastases: assessment of the control dose of micrometastases.
|
Radiat Oncol
|
2010
|
0.83
|
|
51
|
Treatment of hepatic metastases of breast cancer with CT-guided interstitial brachytherapy - a phase II-study.
|
Radiother Oncol
|
2011
|
0.83
|
|
52
|
Phase II feasibility study on the combination of two different regional treatment approaches in patients with colorectal "liver-only" metastases: hepatic interstitial brachytherapy plus regional chemotherapy.
|
Cardiovasc Intervent Radiol
|
2009
|
0.83
|
|
53
|
Appropriate patient instructions can reduce prostate motion.
|
Radiat Oncol
|
2012
|
0.83
|
|
54
|
Percutaneous computed tomography-guided high-dose-rate brachytherapy ablation of breast cancer liver metastases: initial experience with 80 lesions.
|
J Vasc Interv Radiol
|
2012
|
0.82
|
|
55
|
CT-guided Interstitial Brachytherapy of Hepatocellular Carcinoma before Liver Transplantation: an Equivalent Alternative to Transarterial Chemoembolization?
|
Eur Radiol
|
2015
|
0.82
|
|
56
|
[Thermal therapy of prostate cancer using magnetic nanoparticles].
|
Actas Urol Esp
|
2007
|
0.82
|
|
57
|
Changes in hepatic blood flow during whole body hyperthermia.
|
Int J Hyperthermia
|
2010
|
0.82
|
|
58
|
Treatment for liver metastasis from renal cell carcinoma with computed-tomography-guided high-dose-rate brachytherapy (CT-HDRBT): a case series.
|
World J Urol
|
2012
|
0.81
|
|
59
|
18F-FET PET for planning of thermotherapy using magnetic nanoparticles in recurrent glioblastoma.
|
Int J Hyperthermia
|
2006
|
0.81
|
|
60
|
Value of combined PET/CT for radiation planning in CT-guided percutaneous interstitial high-dose-rate single-fraction brachytherapy for colorectal liver metastases.
|
Int J Radiat Oncol Biol Phys
|
2010
|
0.81
|
|
61
|
Stress induced changes in lymphocyte subpopulations and associated cytokines during whole body hyperthermia of 41.8-42.2 degrees C.
|
Eur J Appl Physiol
|
2005
|
0.81
|
|
62
|
Perfusion measurement using DCE-MRI: implications for hyperthermia.
|
Int J Hyperthermia
|
2008
|
0.81
|
|
63
|
Residual translational and rotational errors after kV X-ray image-guided correction of prostate location using implanted fiducials.
|
Strahlenther Onkol
|
2010
|
0.81
|
|
64
|
Introduction: non-invasive thermometry for thermotherapy.
|
Int J Hyperthermia
|
2005
|
0.80
|
|
65
|
Recurrent rectal cancer within the pelvis. A multicenter analysis of 123 patients and recommendations for adjuvant radiotherapy.
|
Strahlenther Onkol
|
2004
|
0.80
|
|
66
|
[Standards and perspectives in locoregional hyperthermia].
|
Wien Med Wochenschr
|
2004
|
0.80
|
|
67
|
Magnetic resonance imaging, computed tomography, and 68Ga-DOTATOC positron emission tomography for imaging skull base meningiomas with infracranial extension treated with stereotactic radiotherapy--a case series.
|
Head Face Med
|
2012
|
0.80
|
|
68
|
Restaging of locally advanced carcinoma of the rectum with MR imaging after preoperative radio-chemotherapy plus regional hyperthermia.
|
Strahlenther Onkol
|
2002
|
0.79
|
|
69
|
Regularized antenna profile adaptation in online hyperthermia treatment.
|
Med Phys
|
2010
|
0.79
|
|
70
|
Radiation-induced liver damage: correlation of histopathology with hepatobiliary magnetic resonance imaging, a feasibility study.
|
Cardiovasc Intervent Radiol
|
2014
|
0.79
|
|
71
|
CT-guided high-dose-rate brachytherapy of unresectable hepatocellular carcinoma.
|
Strahlenther Onkol
|
2014
|
0.79
|
|
72
|
Contribution of (18)F-Fluoro-ethyl-tyrosine Positron Emission Tomography to Target Volume Delineation in Stereotactic Radiotherapy of Malignant Cranial Base Tumours: First Clinical Experience.
|
Int J Mol Imaging
|
2012
|
0.78
|
|
73
|
In vivo assessment of catheter positioning accuracy and prolonged irradiation time on liver tolerance dose after single-fraction 192Ir high-dose-rate brachytherapy.
|
Radiat Oncol
|
2011
|
0.78
|
|
74
|
A non-randomised, single-centre comparison of induction chemotherapy followed by radiochemotherapy versus concomitant chemotherapy with hyperfractionated radiotherapy in inoperable head and neck carcinomas.
|
BMC Cancer
|
2006
|
0.78
|
|
75
|
Image-guided stereotactic radiosurgery for cranial lesions: large margins compensate for reduced image guidance frequency.
|
Anticancer Res
|
2013
|
0.78
|
|
76
|
Whole body hyperthermia induces apoptosis in subpopulations of blood lymphocytes.
|
Immunobiology
|
2003
|
0.78
|
|
77
|
Interfraction rotation of the prostate as evaluated by kilovoltage X-ray fiducial marker imaging in intensity-modulated radiotherapy of localized prostate cancer.
|
Med Dosim
|
2012
|
0.78
|
|
78
|
Preliminary experience with CT-guided high-dose rate brachytherapy as an alternative treatment for hepatic recurrence of cholangiocarcinoma.
|
HPB (Oxford)
|
2012
|
0.77
|
|
79
|
A clinical water-coated antenna applicator for MR-controlled deep-body hyperthermia: a comparison of calculated and measured 3-D temperature data sets.
|
IEEE Trans Biomed Eng
|
2005
|
0.77
|
|
80
|
Simulation of different applicator positions for treatment of a presacral tumour.
|
Int J Hyperthermia
|
2007
|
0.77
|
|
81
|
Quantification of fMRI BOLD signal and volume applied to the somatosensory cortex.
|
Z Med Phys
|
2007
|
0.77
|
|
82
|
Development and evaluation of a three-dimensional hyperthermia applicator with Water-COated Antennas (WACOA).
|
Med Phys
|
2003
|
0.76
|
|
83
|
CT-guided high-dose-rate brachytherapy in the interdisciplinary treatment of patients with liver metastases of pancreatic cancer.
|
Hepatobiliary Pancreat Dis Int
|
2015
|
0.76
|
|
84
|
Hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinosis.
|
J Clin Oncol
|
2004
|
0.76
|
|
85
|
CT-guided brachytherapy (CTGB) versus interstitial laser ablation (ILT) of colorectal liver metastases: an intraindividual matched-pair analysis.
|
Strahlenther Onkol
|
2008
|
0.76
|
|
86
|
In regard to Dr. Vasanthan et al. (Int J Radiat Oncol Biol Phys 2005;61:145-153).
|
Int J Radiat Oncol Biol Phys
|
2005
|
0.76
|
|
87
|
Tumour perfusion assessment during regional hyperthermia treatment: comparison of temperature probe measurement with H(2)(15)O-PET perfusion.
|
Int J Hyperthermia
|
2010
|
0.76
|
|
88
|
Treatment of hepatic metastases from gastric or gastroesophageal adenocarcinoma with computed tomography-guided high-dose-rate brachytherapy (CT-HDRBT).
|
Anticancer Res
|
2012
|
0.76
|
|
89
|
Hyperthermia classic commentary: 'Simulation studies promote technological development of radiofrequency phased array hyperthermia' by Peter Wust et al., International Journal of Hyperthermia 1996;12:477-494.
|
Int J Hyperthermia
|
2009
|
0.76
|
|
90
|
Radiochemotherapy combined with regional pelvic hyperthermia induces high response and resectability rates in patients with nonresectable cervical cancer > or =FIGO IIB "bulky".
|
Int J Radiat Oncol Biol Phys
|
2006
|
0.76
|
|
91
|
Diagnostic value of 123I-IMT SPECT in the follow-up of head and neck cancer.
|
Onkologie
|
2006
|
0.76
|
|
92
|
Differential gene expression in peripheral blood lymphocytes of cancer patients treated with whole body hyperthermia and chemotherapy: a pilot study.
|
Int J Hyperthermia
|
2006
|
0.76
|
|
93
|
The effect of induced hyperthermia on the immune system.
|
Prog Brain Res
|
2007
|
0.76
|
|
94
|
Adjuvant chemotherapy with folinic acid and 5-fluorouracil in patients with locally advanced rectal cancer previously treated by preoperative radiochemotherapy and curative tumor resection.
|
Int J Colorectal Dis
|
2006
|
0.75
|
|
95
|
Image-guided radiotherapy with implanted markers and kilovoltage imaging and 6-dimensional position corrections for intrafractional motion of the prostate.
|
Anticancer Res
|
2013
|
0.75
|
|
96
|
Value of 123I-IMT SPECT for diagnosis of recurrent non-astrocytic intracranial tumours.
|
Neuroradiology
|
2005
|
0.75
|
|
97
|
Re: Lyndon Gommersall, Iqbal S. Shergill, Hashim U. Ahmed et al. Nanotechnology and its relevance to the urologist. Eur Urol 2007;52:368-75.
|
Eur Urol
|
2007
|
0.75
|
|
98
|
Anal carcinoma: surgery does not influence prognosis when performed prior to concurrent radiochemotherapy.
|
Anticancer Res
|
2013
|
0.75
|
|
99
|
Goal-directed therapy of cardiac preload in induced whole-body hyperthermia.
|
Chest
|
2005
|
0.75
|
|
100
|
[Influence of preoperative (hyperthermic) radiochemotherapy on manometric anal sphincter function in locally advanced rectal cancer].
|
Strahlenther Onkol
|
2004
|
0.75
|
|
101
|
Monte Carlo simulation of contrast-enhanced whole brain radiotherapy on a CT scanner.
|
Med Phys
|
2011
|
0.75
|
|
102
|
[They should make thermotherapy more effective. Hot nanoparticles against cancer].
|
MMW Fortschr Med
|
2007
|
0.75
|
|
103
|
Intraluminal brachytherapy of de novo TIPS: a prospective randomized double-blind study.
|
AJR Am J Roentgenol
|
2006
|
0.75
|
|
104
|
CT-guided high-dose-rate brachytherapy of metachronous ovarian cancer metastasis to the liver: initial experience.
|
Anticancer Res
|
2011
|
0.75
|
|
105
|
Permanent interstitial low-dose-rate brachytherapy for patients with low risk prostate cancer: An interim analysis of 312 cases.
|
Strahlenther Onkol
|
2014
|
0.75
|
|
106
|
Assessment of the tolerance dose of the hepatic reticulo-endothelial system (RES) after single fraction HDR-irradiation: an in-vivo study employing SSPIO.
|
Int J Radiat Biol
|
2008
|
0.75
|
|
107
|
Experimental and numerical investigation of feed-point parameters in a 3-D hyperthermia applicator using different FDTD models of feed networks.
|
IEEE Trans Biomed Eng
|
2002
|
0.75
|